If you are seeing this, then there has been an error in rendering the page. Please disable any content blockers (for example, AdBlock or uBlock Origin), and refresh the page.  If that does not work, please also try emptying your browser cache. 

Jboelens
KNichols
GMuschler

Jaap J. Boelens, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY, United States

Karen M. Nichols, Esq
Vertex Pharmaceuticals
Boston, MA, United States

George Muschler, MD
Cleveland Clinic
Cleveland, OH, United States

CLICK TO SEE WHAT OUR CO-CHAIRS ARE SAYING
Why Consensus?
"As we begin the “new wave” of cell and gene therapies, initially these will be available to treat a limited number of rare conditions. By harmonizing eligibility criteria, endpoints, and monitoring standards, we will fast track successful CGT development.

On the other side, wild growth of non-standardized early phase trials will inhibit our ability to accrue high potential trials and advance these critical first products"

Jaap J. Boelens, MD, PhD
Why ISCT?
"ISCT has assembled a remarkable forum and community that blends together experts in stem cell and progenitor cell biology, with engineers, clinicians, regulatory experts, measurement scientists, clinical trial experts, product developers, entrepreneurs, and ethicists. ISCT is the dynamic and diverse community that is unraveling the complexity and building the standards and technology bridges that will bring safe and effective therapies to patients"

George Muschler, MD
Why Now?
"ISCT is uniquely positioned to take on this profound responsibility because it stands at the intersection of science and implementation, and is supported by a membership composed of academic, industry, and regulatory leaders. Now is the time to collaborate with all members of the CGT field to develop enlightened consensus in order to illuminate the path forward"

Karen M. Nichols, Esq
Previous
Next

MEET THE ISCT 2021 NEW ORLEANS VIRTUAL ORGANIZING COMMITTEE – CLICK HERE

Your first glance at our plenary topics and more!

For Sponsors and Exhibitors 

Join us as we prepare for ISCT 2021 New Orleans VIRTUAL!

RE–CONNECT. COMMUNICATE. TRANSLATE. 

Prepare for a Virtual Annual Meeting building on the groundbreaking success of ISCT 2020 Paris Virtual:

  • 50+ presentations with three LIVE tracks, complete with Q&A and on-demand access to follow
  • Themed program content segments addressing the core issues in cell and gene therapy translation
  • The return of our cutting edge virtual environment – with new improvements for user experience

Bookmark this site and subscribe for updates!